Avanos Medical (AVNS) Non-Current Deferred Tax Liability (2016 - 2024)
Historic Non-Current Deferred Tax Liability for Avanos Medical (AVNS) over the last 11 years, with Q3 2024 value amounting to $23.9 million.
- Avanos Medical's Non-Current Deferred Tax Liability fell 1672.47% to $23.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $23.9 million, marking a year-over-year decrease of 1672.47%. This contributed to the annual value of $70.7 million for FY2023, which is 56.26% down from last year.
- As of Q3 2024, Avanos Medical's Non-Current Deferred Tax Liability stood at $23.9 million, which was down 1672.47% from $23.4 million recorded in Q2 2024.
- In the past 5 years, Avanos Medical's Non-Current Deferred Tax Liability ranged from a high of $71.1 million in Q4 2022 and a low of $5.6 million during Q1 2021
- Over the past 5 years, Avanos Medical's median Non-Current Deferred Tax Liability value was $25.1 million (recorded in 2023), while the average stood at $32.6 million.
- Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first surged by 266000.0% in 2020, then plummeted by 5942.03% in 2021.
- Over the past 5 years, Avanos Medical's Non-Current Deferred Tax Liability (Quarter) stood at $66.7 million in 2020, then dropped by 6.9% to $62.1 million in 2021, then rose by 14.49% to $71.1 million in 2022, then fell by 0.56% to $70.7 million in 2023, then plummeted by 66.2% to $23.9 million in 2024.
- Its last three reported values are $23.9 million in Q3 2024, $23.4 million for Q2 2024, and $23.6 million during Q1 2024.